Your session is about to expire
← Back to Search
JNJ-42847922 for Kidney Failure
Study Summary
This trial is testing a new drug to see how well it works in people with different levels of kidney function.
- Kidney Failure
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Has JNJ-42847922 been tested in past clinical studies?
"Currently, 6 clinical trials are in progress for JNJ-42847922 with 2 of them being Phase 3. Knoxville, Tennessee is one hub where studies are conducted; however there exist 413 other sites carrying out research related to this compound."
Has research of this type ever been conducted before?
"JNJ-42847922 was first studied in 2020, with a Phase 1 trial sponsored by Janssen Research & Development. After successful results were achieved, the medication received its approval and there are currently 6 ongoing studies spanning 28 countries and 133 cities."
For whom is this trial appropriate?
"Patients that satisfy the age criteria (18-80) and have declining renal function can apply to be part of this 32-person trial."
Are there any openings to join this medical experiment at present?
"As indicated on clinicaltrials.gov, this medical study is currently seeking participants; its inception was March 31st 2021 and it has recently been updated November 9th 2022."
Has the FDA sanctioned JNJ-42847922 for medicinal use?
"JNJ-42847922's safety is rated a 1 since this Phase 1 trial has scarce evidence of its efficacy as well as limited data outlining the medication's safety."
How many participants is this clinical trial seeking to enroll?
"Affirmative, according to clinicaltrials.gov the research is actively enrolling participants. It was first posted on March 31st 2021 and updated as recently as November 9th 2022. This medical study seeks out 32 patients from 2 locations for its experimentations."
Could minors aged under 20 years partake in this trial?
"This clinical study is open to trial participants aged 18-80. For individuals younger than 18 and older than 65, there are 7 trials and 162 trials respectively available."
Share this study with friends
Copy Link
Messenger